Edit

Sabre Partners

http://sabre-partners.com
Last activity: 10.07.2026
Active
Invests in categories: CareDevelopmentFinTechHealthTechHomeMedTechPlatformProviderResearchService
Portfolio
10
Mentions
8
Investment Stage: Series A; Series B; Series C

Portfolio 10

DateNameWebsiteTotal RaisedLocation
17.03.2022ekincareekincare.com$20.87MIndia, Tel...
29.07.2021Stratastrataprop.com$6MIndia, Kar...
21.11.2017Porteaportea.com$71.75MIndia, Kar...
-Veeda Clin...veedacr.com-India, Guj...
-Card91card91.io$13MIndia, Kar...
-AVIOM Indi...aviom.in$30MIndia, Del...
-DCB Bank L...dcbbank.com--
-CoinTribecointribe.com--
-HungerBoxhungerbox.com$16.06MIndia, Kar...
-HealthCare...hcgoncology.com-India, Kar...

Mentions in press and media 8

DateTitleDescription
10.07.2026Claims adjudication SaaS platform Superclaims acquired by ekincareAI-powered claims adjudication SaaS platform Superclaims has been bought by digital health platform Ekincare. As part of the acquisition, Maneesh Daithala, cofounder and CTO of Superclaims, and Bhavish Ramaswamy, cofounder and CEO of Superc...
30.01.2024India-focused mid-market PE Sabre Partners raises $73m for new fundIndia-focused mid-market private equity firm Sabre Partners has raised around $73 million for its fourth fund to back companies in fintech, healthcare and health tech sectors, a top executive told DealStreetAsia.
17.03.2022Healthtech Startup ekincare Secures $15 Mn From HealthQuad And Sabre PartnersHyderabad-based healthtech startup ekincare has raised $15 Mn in a Series B funding led by HealthQuad and Sabre Partners with participation from existing investors Ventureast, Eight Roads Ventures, Siana Capital and Endiya Partners. The sta...
17.03.2022Ekincare raises $15 million in funding led by HealthQuad, Sabre PartnersHealth benefits startup Ekincare has raised $15 million in a Series B funding round led by HealthQuad and Sabre Partners, a senior company official told ET. Existing investors Ventureast, Eight...
23.08.2016Romulus Capital Leads $14M Series C for Vyome BiosciencesVyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced today that it has closed a $14 million Series C financing round. This fina...
23.08.2016Perceptive Advisors Leads $14M Series C for Vyome BiosciencesVyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced today that it has closed a $14 million Series C financing round. This fina...
13.08.2014Vyome Biosciences Raises $8M in Series B FundingVyome Biosciences, a Delhi, India-based dermatology company, raised $8m in Series B funding. The round was led by Sabre Partners with participation from existing investors Kalaari Capital and Aarin Capital. The company intends to use the fu...
-Portea Medical Raises $26 Mn Funding From Sabre Partners, MEMG CDCBengaluru-based home healthcare startup Portea Medical has raised $26 Mn funding in a Series C round led by Sabre Partners and MEMG CDC Ventures. Existing investors Accel, Washington-headquartered International Finance Corporation (IFC) and...

Reviews 0

Sign up to leave a review

Sign up Log In